Faes Farma SA
Research Faes Farma SA (FAE) on Bullrun: valuation model: 9.2% undervalued, market cap EUR 1.42B, P/E 16.9, dividend yield 2.8%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerFAE
- ExchangeMC
- CountrySpain
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyEUR
- Valuation signal9.2% undervalued
- Market capEUR 1.42B
- P/E16.9
- Dividend yield2.8%
- Financial periodQ1 2026
- RevenueEUR 200.07M
- Net incomeEUR 30.79M
- Gross margin69.2%
Valuation Snapshot
Bullrun's latest valuation model marks Faes Farma SA as 9.2% undervalued; latest market cap is EUR 1.42B; P/E is 16.9; dividend yield is 2.8%.
Peer valuation comparison
Latest P/E is 16.89x versus a Healthcare sector median of 24.46x (31.0% below).
Latest dividend yield is 2.81% versus a Healthcare sector median of 2.11% (33.2% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | EUR 626.99M | EUR 79.63M | EUR 62.39M | 63.8% | 0.25 | EUR 117.31M | EUR 433.29M | EUR 745.59M |
| FY2024 | EUR 510.04M | EUR 111.36M | EUR 81.65M | 65.9% | 0.36 | EUR 64.22M | EUR 26.29M | EUR 726.62M |
| FY2023 | EUR 473.09M | EUR 91.90M | EUR 5.21M | 66.0% | 0.3 | EUR 34.65M | EUR 28.51M | EUR 663.41M |
| FY2022 | EUR 461.72M | EUR 89.50M | EUR 31.83M | 64.8% | 0.29 | EUR 66.41M | EUR 37.04M | EUR 602.40M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | EUR 1.42B | 16.9 | 2.8% | 0.13 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.13 EUR, yield 2.8%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.18 EUR |
| FY2024 | 0.16 EUR |
| FY2023 | 0.04 EUR |
| FY2022 | 0.03 EUR |
About Faes Farma SA
Faes Farma, S.A., researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials internationally. The company operates through Pharmaceutical and Healthcare Specialties; Animal Nutrition and Health; and Pharmaceutical Raw Materials segments.
Related stock research
Other Healthcare stocks
Frequently asked questions
Is Faes Farma SA overvalued or undervalued?
Bullrun's valuation model currently marks Faes Farma SA as 9.2% undervalued.
What is Faes Farma SA's market cap?
Faes Farma SA's market capitalization is EUR 1.42B.
What is Faes Farma SA's P/E ratio?
Faes Farma SA's price-to-earnings (P/E) ratio is 16.9.
Does Faes Farma SA pay a dividend?
Faes Farma SA has a dividend yield of 2.8%.
What does Faes Farma SA do?
Faes Farma, S.A., researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials internationally. The company operates through Pharmaceutical and Healthcare Specialties; Animal Nutrition and Health; and Pharmaceutical Raw Materials segments.